CLOSE
Enter Website

Our site stores cookies on your computer. These cookies are used to offer more personalised services and improve each day. Continuing to browse our site implies acceptance of our cookie policy. See our legal notes or Close

_01

Expertise Line

API

In our production sites we mill a broad range of drug substances in multipurpose equipment with proven experience.

HPAPI

We are equipped with containment solutions (Glove- and Half Suit Boxes) to mill highly potent ingredients.

STEROID

This product category can be processed thanks to dedicated micronization lines.

FOOD & EXCIPIENT

In our production sites, excipients are milled in GMP equipment. The food ingredients are processed in dedicated lines with the same standard we are used to apply to pharmaceuticals.

_02

Service Line

JET-, PIN- AND HAMMER MILLING

We provide to our customers micronization and milling services with a deep experience in the particle size reduction.

CO-MICRONIZATION

The simultaneous micronization of at least two compounds improves powder properties and skip potential blending steps.

MICRONIZATION UNDER CONTAINMENT

We provide to our customers particle size reduction by jet milling to very low temperature, for those compounds with a low brittleness and tacky, elastic polymers or semi-solid in nature. It is also used to prevent the degradation of highly sensitive products, to avoid polymorphic changes and to avoid any increase in amorphous particles.

POST MILLING CONDITIONING

We are equipped with containment isolators, as part of a systematic approach to control the safe handling for potent compound.

QUALITY BY DESIGN

With product conditioning we are able to resolve post micronization morphological issues.

CRYOGENIC MICRONIZATION

Before the Process Validation activity, we support our customers with an approach to QbD by the identification of the Critical Process Parameters (CPP), to be studied during the following Design of Experiment (DoE) development step.

ANALYTICAL SERVICES

We provide services for PSD analysis and related activities as method development, method validation, method transfer, etc. with our cutting-edge equipment.

_03

Strategy Line

CONFIDENTIALITY

We guarantee a full confidentiality to our customers which rely on us as part of the development of new compounds.

INDEPENDENCE

The company, firmly in the hands of the founder’s second generation, continues along the path of complete independence able to ensure flexibility and avoid any conflict of interest towards its clients.

BUSINESS CONTINUITY PLAN

We ensure our customers having created a system of prevention and recovery from potential threats to the company.

ADVISORY SUPPORT

We accompany our clients with expertise, supporting them with regular consulting services for each step of the projects.

PARTNERSHIP

We consider our expertise and experience as basic concept for a long-lasting partnership with our customers.

_04

Key Factor

LEAD TIME

We provide a smart management of the projects evaluating the overall duration of the critical path in order to save time by accomplish customer´s needs.

FLEXIBILITY

We accommodate the needs of our customers adapting the day-to-day shifts with the willingness and ability to readily respond to changing circumstances and expectations.

RESILIENCE

We have the capacity to recover quickly from difficulties, knowing how to face the challenges we experience every day.

News

22 ottobre 2019
CPhI Worldwide Frankfurt 2019

We will be pleased to welcome you at our exhibition booth during the 30th CPhI Worldwide in Frankfurt, Germany (5 – 7 November 2019). MUnit, your partner for the micronisation of API’s and High Potent Materials, will be pleased to welcome you at Booth 40B10. Please, check our video invitation below and visit us at …

14 agosto 2019
6th Controlled and Modified Drug Release Summit & 9th American DDF Summit

MUNIT announces its participation at the 6th Controlled and Modified Drug Release Summit (August 27th – 29th 2019) in Philadelphia and the 9th American DDF Summit in Boston, September 9th – 10th 2019. Our sales team would be delighted to welcome you at our booth.

26 aprile 2019
FDD Europe London and RDD Lisbon

We will be pleased to welcome you at our exhibition booth during the 5th Annual Formulation & Drug Delivery Congress in London (29 – 30 April 2019) and the Respiratory Drug Delivery Europe congress 2019 in Lisbon, Portugal, May 7-10, 2019.

15 marzo 2019
FFD US, DCAT & CPhI Japan

Munit will participate the the this years Formulation and Drug Delivery Summit in San Diego (USA) DCAT New York (USA) and CPhI Tokyo (Japan). We are looking forward seeing you at one of this events!

Jetpharma

 

Mr. Maurizio Schiavazzi

Commercial Director

mschiavazzi(a)munit.com

Jetpharma

 

Mr. Giovanni Frigerio

Technical Director

gfrigerio(a)munit.com

Jetpharma

 

Ms. Katia Zocca

Customer Care

kzocca(a)munit.com

Jetpharma

 

Mr. Uwe Heidenreich

Business Development Manager

uheidenreich(a)munit.com

Jetpharma

 

Mr. Massimo Dal Bosco

Business Development Manager

mdalbosco(a)munit.com

Jetpharma

MUNIT SA
Via Crocicchio Cortogna 6
CH-6900 Lugano

Jetpharma

T. +41 (0)91 910 30 80

Jetpharma

contact(at)munit.com